                         SEQUENCE LISTING

<110>  DiaMedica Inc.
       Williams, Mark
       Charles, Matthew
 
<120>  COMPOSITIONS AND METHODS FOR TREATING DIABETES

<130>  DIAM-001/02WO 316251-2084

<150>  US 61/483,412
<151>  2011-05-06

<150>  US 61/523,010
<151>  2011-08-12

<150>  US 61/565,926
<151>  2011-12-01

<150>  US 61/566,481
<151>  2011-12-02

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  262
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Trp Phe Leu Val Leu Cys Leu Ala Leu Ser Leu Gly Gly Thr Gly 
1               5                   10                  15      


Ala Ala Pro Pro Ile Gln Ser Arg Ile Val Gly Gly Trp Glu Cys Glu 
            20                  25                  30          


Gln His Ser Gln Pro Trp Gln Ala Ala Leu Tyr His Phe Ser Thr Phe 
        35                  40                  45              


Gln Cys Gly Gly Ile Leu Val His Arg Gln Trp Val Leu Thr Ala Ala 
    50                  55                  60                  


His Cys Ile Ser Asp Asn Tyr Gln Leu Trp Leu Gly Arg His Asn Leu 
65                  70                  75                  80  


Phe Asp Asp Glu Asn Thr Ala Gln Phe Val His Val Ser Glu Ser Phe 
                85                  90                  95      


Pro His Pro Gly Phe Asn Met Ser Leu Leu Glu Asn His Thr Arg Gln 
            100                 105                 110         


Ala Asp Glu Asp Tyr Ser His Asp Leu Met Leu Leu Arg Leu Thr Glu 
        115                 120                 125             


Pro Ala Asp Thr Ile Thr Asp Ala Val Lys Val Val Glu Leu Pro Thr 
    130                 135                 140                 


Glu Glu Pro Glu Val Gly Ser Thr Cys Leu Ala Ser Gly Trp Gly Ser 
145                 150                 155                 160 


Ile Glu Pro Glu Asn Phe Ser Phe Pro Asp Asp Leu Gln Cys Val Asp 
                165                 170                 175     


Leu Lys Ile Leu Pro Asn Asp Glu Cys Lys Lys Ala His Val Gln Lys 
            180                 185                 190         


Val Thr Asp Phe Met Leu Cys Val Gly His Leu Glu Gly Gly Lys Asp 
        195                 200                 205             


Thr Cys Val Gly Asp Ser Gly Gly Pro Leu Met Cys Asp Gly Val Leu 
    210                 215                 220                 


Gln Gly Val Thr Ser Trp Gly Tyr Val Pro Cys Gly Thr Pro Asn Lys 
225                 230                 235                 240 


Pro Ser Val Ala Val Arg Val Leu Ser Tyr Val Lys Trp Ile Glu Asp 
                245                 250                 255     


Thr Ile Ala Glu Asn Ser 
            260         


<210>  2
<211>  262
<212>  PRT
<213>  Homo sapiens

<400>  2

Met Trp Phe Leu Val Leu Cys Leu Ala Leu Ser Leu Gly Gly Thr Gly 
1               5                   10                  15      


Ala Ala Pro Pro Ile Gln Ser Arg Ile Val Gly Gly Trp Glu Cys Glu 
            20                  25                  30          


Gln His Ser Gln Pro Trp Gln Ala Ala Leu Tyr His Phe Ser Thr Phe 
        35                  40                  45              


Gln Cys Gly Gly Ile Leu Val His Arg Gln Trp Val Leu Thr Ala Ala 
    50                  55                  60                  


His Cys Ile Ser Asp Asn Tyr Gln Leu Trp Leu Gly Arg His Asn Leu 
65                  70                  75                  80  


Phe Asp Asp Glu Asn Thr Ala Gln Phe Val His Val Ser Glu Ser Phe 
                85                  90                  95      


Pro His Pro Gly Phe Asn Met Ser Leu Leu Glu Asn His Thr Arg Gln 
            100                 105                 110         


Ala Asp Glu Asp Tyr Ser His Asp Leu Met Leu Leu Arg Leu Thr Glu 
        115                 120                 125             


Pro Ala Asp Thr Ile Thr Asp Ala Val Lys Val Val Glu Leu Pro Thr 
    130                 135                 140                 


Gln Glu Pro Glu Val Gly Ser Thr Cys Leu Ala Ser Gly Trp Gly Ser 
145                 150                 155                 160 


Ile Glu Pro Glu Asn Phe Ser Phe Pro Asp Asp Leu Gln Cys Val Asp 
                165                 170                 175     


Leu Lys Ile Leu Pro Asn Asp Glu Cys Lys Lys Val His Val Gln Lys 
            180                 185                 190         


Val Thr Asp Phe Met Leu Cys Val Gly His Leu Glu Gly Gly Lys Asp 
        195                 200                 205             


Thr Cys Val Gly Asp Ser Gly Gly Pro Leu Met Cys Asp Gly Val Leu 
    210                 215                 220                 


Gln Gly Val Thr Ser Trp Gly Tyr Val Pro Cys Gly Thr Pro Asn Lys 
225                 230                 235                 240 


Pro Ser Val Ala Val Arg Val Leu Ser Tyr Val Lys Trp Ile Glu Asp 
                245                 250                 255     


Thr Ile Ala Glu Asn Ser 
            260         


<210>  3
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward primer

<400>  3
tggcgtatgt gtggaaccg                                                    19


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reverse primer

<400>  4
ctcgcagtag ggaacagcaa                                                   20


<210>  5
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward primer

<400>  5
ctggatagcc tttcttctgc tg                                                22


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  reverse primer

<400>  6
gcacactgtg tccgaactca                                                   20


